184 related articles for article (PubMed ID: 37475935)
1. Retracted: Association between Immunohistochemistry Markers and Tumor Features and Their Diagnostic and Prognostic Values in Intrahepatic Cholangiocarcinoma.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9837859. PubMed ID: 37475935
[TBL] [Abstract][Full Text] [Related]
2. Retracted: Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9815947. PubMed ID: 37565164
[TBL] [Abstract][Full Text] [Related]
3. Retracted: Expression of Tspan8 in Patients with Intrahepatic Cholangiocarcinoma and Its Relationship with Clinicopathological Features and Prognosis.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9834798. PubMed ID: 37387978
[TBL] [Abstract][Full Text] [Related]
4. Retracted: Application Value of Contrast-Enhanced Ultrasound Combined with Enhanced MR Scanning in Patients with Intrahepatic Cholangiocarcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9876728. PubMed ID: 37476736
[TBL] [Abstract][Full Text] [Related]
5. Association between Immunohistochemistry Markers and Tumor Features and Their Diagnostic and Prognostic Values in Intrahepatic Cholangiocarcinoma.
He J; Zhang C; Shi Q; Bao F; Pan X; Kuai Y; Wu J; Li L; Chen P; Huang Y; Xu J
Comput Math Methods Med; 2022; 2022():8367395. PubMed ID: 35529254
[TBL] [Abstract][Full Text] [Related]
6. Expression and prognostic value of soluble CD97 and its ligand CD55 in intrahepatic cholangiocarcinoma.
Meng ZW; Liu MC; Hong HJ; Du Q; Chen YL
Tumour Biol; 2017 Mar; 39(3):1010428317694319. PubMed ID: 28345461
[TBL] [Abstract][Full Text] [Related]
7. [Predictive value of prognostic inflammatory and tumor score in intrahepatic cholangiocarcinoma].
Ma BQ; Meng HJ; Dong XF; Gao XL; Wu YN; Zhang W; Li SP; Shen A
Zhonghua Gan Zang Bing Za Zhi; 2022 Jul; 30(7):777-783. PubMed ID: 36038350
[No Abstract] [Full Text] [Related]
8. Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma.
Yao X; Wang X; Wang Z; Dai L; Zhang G; Yan Q; Zhou W
Onco Targets Ther; 2012; 5():255-61. PubMed ID: 23091390
[TBL] [Abstract][Full Text] [Related]
9. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW
Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
[TBL] [Abstract][Full Text] [Related]
10. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?
Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF
Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels.
Lin ZY; Liang ZX; Zhuang PL; Chen JW; Cao Y; Yan LX; Yun JP; Xie D; Cai MY
BMC Cancer; 2016 Oct; 16(1):792. PubMed ID: 27733196
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of immunohistochemical markers for differential diagnosis of hepatocelluar carcinoma and cholangiocarcinoma.
Ryu HS; Lee K; Shin E; Kim SH; Jing J; Jung HY; Lee H; Jang JJ
Tumori; 2012; 98(4):478-84. PubMed ID: 23052165
[TBL] [Abstract][Full Text] [Related]
14. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
[TBL] [Abstract][Full Text] [Related]
15. Intrahepatic cholangiocarcinoma in Korea.
Kim HJ; Yun SS; Jung KH; Kwun WH; Choi JH
J Hepatobiliary Pancreat Surg; 1999; 6(2):142-8. PubMed ID: 10398901
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of microvessel density in intrahepatic cholangiocarcinoma.
Bunsiripaiboon P; Sornmayura P; Wilasrusmee C; Lertsithichai P
J Med Assoc Thai; 2010 Jan; 93(1):66-72. PubMed ID: 20196413
[TBL] [Abstract][Full Text] [Related]
17. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
Su MC; Hsu C; Kao HL; Jeng YM
Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
[TBL] [Abstract][Full Text] [Related]
18. An Intrahepatic Cholangiocarcinoma with Focal Rhabdoid Features and SMARCA4-Deficiency.
Minato H; Yoshikawa A; Katayanagi K; Kurumaya H; Kato K; Kitamura H
Int J Surg Pathol; 2022 Aug; 30(5):581-585. PubMed ID: 34955041
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma.
Huang YH; Zhang CZ; Huang QS; Yeong J; Wang F; Yang X; He YF; Zhang XL; Zhang H; Chen SL; Zheng YL; Deng R; Lin CS; Yang MM; Li Y; Jiang C; Kin-Wah Lee T; Ma S; Zeng MS; Yun JP
J Hepatol; 2021 Apr; 74(4):838-849. PubMed ID: 33212090
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic and prognostic value of MRP8/MRP14 in intrahepatic cholangiocarcinoma.
Jin GZ; Dong W; Dong H; Yu H; Chen J; Yu WL; Li AJ; Cong WM; Wu MC
Oncotarget; 2015 Nov; 6(36):39357-64. PubMed ID: 26472105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
